tiprankstipranks
pc:crani

CraniUS Therapeutics

CraniUS Therapeutics is a privately held neurotechnology company developing a fully implantable, skull-embedded platform (NeuroPASS™) to bypass the blood-brain barrier for targeted drug delivery and monitoring in the brain. The company focuses on transforming cranial implants into active therapeutic interfaces to support long-term outpatient care for neurological diseases and brain cancer.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$20M
Total Amount Raised$20M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$20M
Latest Funding Amount$20M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 28, 2026
Series B
$20.00M

Investors

Investor Name
Funding Round

Related News and Analysis